In November 2007, 23andMe’s first DNA test cost $999. Eighteen years and one bankruptcy later, MyHeritage sells a genuinely more capable test — full whole-genome sequencing rather than a targeted chip — for as little as $19.90. Over roughly the same period, an Ancestry World Explorer subscription has gone from around $299 a year to as much as $720 a year at full monthly pricing. That trajectory raises a real question for anyone budgeting a genealogy hobby: has the DNA test become the cheap way in, with the records subscription doing the actual monetizing? The honest answer, once the full history and five different companies are considered, is yes for some companies, no for others, and something else entirely for the one company that never had a subscription at all.

The Full Arc of DNA Testing Prices

FamilyTreeDNA has the longest continuous price history of any company covered here, not 23andMe. It launched the industry’s first direct-to-consumer Y-DNA test in May 2000, seven years before 23andMe existed at all.¹ That original 12-marker test settled in around $99 for surname-project participants within its first few years — a price documented in contemporary news coverage and academic sources from the mid-2000s² — and by February 2013, when FamilyTreeDNA cut that same basic test to $39, the company explicitly framed it as a 60 percent reduction from that long-standing baseline, removing “cost as a barrier” to “universal access” to genetic genealogy.³ In other words, FamilyTreeDNA’s entry-level test held remarkably close to $99 for roughly a decade before this article’s price-war and subscription-pricing comparisons even begin.

23andMe’s history is shorter but far more dramatic in absolute terms, and it’s worth tracing in full. The company launched in November 2007 at $999, cut that to $399 within a year, and by July 2009 introduced a specific $99 tier explicitly tied to what it called a “Research Revolution” — participants who took the cheap test agreed to complete health surveys feeding disease-specific research studies.⁴ That $99 research kit is worth pausing on: it is a precisely dated, explicitly stated example of a company using an ultra-cheap DNA test to build something other than a customer base for a records subscription. By May 2012, 23andMe dropped its price further to $299 and eliminated subscription pricing entirely in favor of a single payment; later that year it matched AncestryDNA’s newly launched $99 price point.⁵

AncestryDNA’s own history is comparatively simple on the surface: $99 at its 2012 US launch, and $99 today.⁶ But that list price has rarely reflected what people actually paid. The clearest example is the documented “price war” of late 2017 into early 2018, when MyHeritage’s aggressive market entry pushed 23andMe, MyHeritage, and FamilyTreeDNA kits as low as $49 for multi-kit purchases, and AncestryDNA itself sat at $79 for six consecutive months before returning to $99 in April 2018.⁷ FamilyTreeDNA’s flagship Family Finder kit has otherwise held remarkably steady at $79 from at least a 2018 review through current 2026 pricing,⁸ with periodic sales as low as $39.⁹

MyHeritage’s current pricing is the most striking data point of all. Its kit, nominally $89, is routinely available for $19.90 to $32 during recurring promotions¹⁰ — and unlike a decade ago, that cheap kit now performs whole-genome sequencing, a shift covered in depth elsewhere on this site, reading roughly 3 billion base pairs rather than the roughly 700,000 a standard chip test covers.¹¹ That’s a case of a lower promotional price coinciding with a substantially better product, not a shrinking one. FamilyTreeDNA’s own move to Next Generation Sequencing technology, covered on this site last month, tells a similar story: roughly 400 times more usable data at no change to list price.¹² Some of this generosity likely reflects genuine technological cost declines across the sequencing industry generally, not purely competitive pressure — the same underlying lab technology has gotten cheaper for everyone, genealogy company or not. Living DNA, the fifth major player, has been the exception to nearly every trend described here for most of this history: consistently the most expensive kit of the group, priced around $124, and rarely approaching the deep promotional lows the other four have offered.¹³ That may be starting to shift, however — as of this writing, Living DNA is running a sale price of $99 on its basic test, its lowest offer in some time and a notable break from its usual pricing discipline.

What Membership Has Actually Cost

The subscription side of the industry is where a real, industry-wide claim breaks down into company-specific stories. Ancestry’s own corporate blog is explicit that the price increase implemented February 1, 2022 — to $24.99, $39.99, and $49.99 per month for its three US membership tiers — was “the first subscription price increase since 2013.”¹⁴ Ancestry’s records subscription, in other words, was priced essentially flat for nine years, through the exact period AncestryDNA was aggressively growing its testing database, and only began climbing afterward. A genealogist who paid roughly $299 for an annual World Explorer subscription in 2015¹⁵ would, by 2026, be looking at $338 to $720 a year depending on billing structure.¹⁶

MyHeritage tells a notably different story. Its Complete Plan — the tier most comparable to Ancestry’s top offerings — was priced at $299 a year in a 2017 review¹⁷ and is still commonly cited at $299 a year in sources dated as recently as January 2026.¹⁸ Whatever else has changed at MyHeritage over the past decade, its headline annual subscription price has not moved. That is a meaningful data point against treating “subscriptions keep getting more expensive” as an industry-wide rule rather than a company-specific decision.

Does Ownership History Explain Any of This?

A striking pattern emerges when subscription pricing is set against who actually owns these companies. Ancestry was acquired by the private equity firm Blackstone for $4.7 billion in August 2020.¹⁹ Roughly eighteen months later, in February 2022, came the first subscription price increase in nine years. MyHeritage was acquired by another private equity firm, Francisco Partners, in February 2021²⁰ — and its headline subscription price has not moved since. FamilyTreeDNA’s parent company, Gene by Gene, merged with the Australian genomics company myDNA in January 2021²¹ — a company with no genealogy background at all, built around pharmacogenomics and wellness testing, whose arrival prompted genuine concern in the genetic genealogy community about where FamilyTreeDNA’s product focus would head next.²² Three of the five companies covered here, in other words, changed hands within roughly the same six-month window in 2020 and 2021.

The most immediately relevant development from that ownership shuffle is brand new: as of just this past week, MyHeritage launched Y-DNA results built on existing customer data, in explicit partnership with FamilyTreeDNA, whose products MyHeritage is now rebranding.²³ Whether that partnership eventually pressures FamilyTreeDNA’s pricing — historically the default destination for genealogists wanting Y-DNA specifically — or instead simply expands the market for both companies, is a genuinely open question worth watching. It is far too early to draw a conclusion, but the timing, arriving from two companies that share a 2021 ownership transition, is difficult to read as pure coincidence.

None of this proves that private equity ownership causes price increases; correlation across three data points over five years is suggestive at best, and Ancestry may well have raised prices in 2022 regardless of who owned it. But the pattern is real enough to note: the one company whose subscription price has stayed flat, MyHeritage, is under the same type of ownership as the one whose price has risen sharply, Ancestry — which suggests ownership structure alone doesn’t determine the outcome, and each company’s specific competitive position and product strategy likely matters more than who signs the checks at the top.

The Company Whose Loss Leader Pointed Somewhere Else

23andMe’s story is usually told as the cautionary tale that breaks the loss-leader thesis: no records subscription, a $6 billion peak valuation, Chapter 11 bankruptcy in March 2025, and a $305 million sale — roughly 5 percent of that peak — to TTAM Research Institute, a nonprofit founded by the company’s own former CEO.²⁴ That framing is only half right. 23andMe’s 2009 “Research Revolution” $99 kit shows the company understood the loss-leader logic perfectly well from very early on — it simply pointed the cheap DNA kit toward a different destination than Ancestry or MyHeritage did. Rather than subsidizing entry into a genealogical records subscription, 23andMe subsidized entry into a health-and-research database, later monetized through partnerships like its multi-year collaboration with GlaxoSmithKline. The loss-leader concept still applies; the “back end” being protected was pharmaceutical and health data, not records access.

Read that way, 23andMe’s collapse is less a refutation of the loss-leader strategy than a demonstration of how it can fail: a health-and-research-data business is exposed to risks — a catastrophic data breach affecting nearly seven million customers, collapsed drug-development partnerships, and public trust concerns specific to health genetics — that a straightforward records subscription simply doesn’t carry to the same degree.²⁵ The lesson isn’t that cheap DNA testing without a second product is doomed; it’s that which second product a company chooses to build behind the cheap kit determines what can go wrong.

Is This Actually a Loss-Leader Strategy?

The evidence supports a qualified yes, company by company, rather than one clean answer for the industry. Ancestry’s DNA kit price has been essentially flat for fourteen years, its records subscription was flat for nine of those years while the DNA database was actively growing, and only began rising in 2022, roughly eighteen months after a $4.7 billion private equity acquisition. MyHeritage’s flat decade-long subscription price, held by the same type of private equity owner, argues against extending that conclusion industry-wide. FamilyTreeDNA never built a comparable records subscription at all, monetizing instead through a menu of specialized DNA products layered on a stable base price that has held close to $99, then $79, for roughly a quarter century — and is now, through its new owner’s Y-DNA partnership with MyHeritage, entering unfamiliar competitive territory. And 23andMe ran the loss-leader playbook as deliberately as anyone, just aimed at health and pharmaceutical data instead of genealogical records, with a collapse that reflects the particular risks of that target rather than a failure of the strategy itself.

For Dillman Researchers

The practical takeaway holds regardless of which company’s strategy is at work: a DNA kit remains, by a wide margin, the cheapest entry point into any of these platforms, and that has been true for the entire quarter-century this industry has existed — arguably since FamilyTreeDNA’s original $99 Y-DNA test in the early 2000s. The records subscription that follows is where the real, and unevenly rising, cost sits. For a DFA member weighing whether to test with a new platform versus committing to an annual records subscription, this history suggests testing first, on sale, costs little and holds its value regardless of which company is behind it; committing to a subscription is the decision worth comparison-shopping, since MyHeritage’s stable pricing and Ancestry’s rising pricing are no longer the same bet they were a decade ago. And for anyone specifically weighing a Y-DNA test through FamilyTreeDNA, the newly announced MyHeritage partnership is worth watching over the next few months before committing — it’s too soon to know what it will mean for pricing or product direction, but it is clearly a live, developing story.

Sources

1. Wikipedia. “FamilyTreeDNA.” Accessed August 2026. en.wikipedia.org.
2. NBC News, “Genetic Testing on the Cheap,” and Stanford University, “Genetic Genealogy, Page 4.” Accessed August 2026. nbcnews.com.
3. PRNewswire. “Family Tree DNA Unveils $39 DNA Test in Major Step Toward Universal Access.” February 20, 2013. prnewswire.com.
4. TechCrunch. “23andMe Launches $99 Kit To Spur Its ‘Research Revolution.'” July 2009. techcrunch.com.
5. 23andMe. “23andMe Lowers Price Again, Ends Subscriptions.” May 11, 2012. mediacenter.23andme.com.
6. Data Mining DNA. “How Much Does An AncestryDNA Kit Cost?” Accessed August 2026. dataminingdna.com.
7. The DNA Geek. “The End of the Price War.” April 9, 2018. thednageek.com.
8. The DNA Geek. “The End of the Price War” (Living DNA pricing). April 9, 2018. thednageek.com.
9. PCWorld. “FamilyTreeDNA Review: Unique Genealogical Collaboration, But an Outdated Interface.” December 14, 2018. pcworld.com.
10. Genealogy Bargains. “Hot DNA Deals on mtDNA & Y-DNA Tests: FamilyTreeDNA Summer Sale 2025.” August 2025. genealogybargains.com.
11. Groupon. “MyHeritage Coupon Code.” August 2026. groupon.com.
12. Who Do You Think You Are Magazine. “This Industry-Leading DNA Kit Has Dropped to Under £20.” June 2026. whodoyouthinkyouaremagazine.com.
13. Dillman Family Association. “FamilyTreeDNA’s New Test Delivers 400 Times More Data — But Only If You Actually Swab.” August 15, 2026. dillmanfamilyassociation.org.
14. Ancestry.com. “We’re Increasing Our Monthly Subscription Prices to Help Provide You With More Content and New Product Features.” Accessed August 2026. ancestry.com.
15. Geanamusings. “Ancestry.com Subscription Rates – Are They Changing? UPDATED.” June 2015. geneamusings.com.
16. Ancestry.com “Welcome Back” offer page and Family Tree Magazine, “Ancestry.com Subscriptions Explained.” Accessed August 2026. ancestry.com.
17. Family History Daily. “Get a MyHeritage Free Trial of the Complete Plan.” April 9, 2017. familyhistorydaily.com.
18. Columbus.gov Smart Columbus News aggregator. “MyHeritage Subscription Cost: Is It Worth It?” January 5, 2026. smart.columbus.gov.
19. Genealogy Explained. “Who Owns MyHeritage? What You Need to Know.” Accessed August 2026. genealogyexplained.com.
20. Anglo-Celtic Connections. “MyHeritage Does Y-DNA.” August 20, 2026. anglocelticconnections.ca.
21. Wikipedia. “FamilyTreeDNA” (ownership section). Accessed August 2026. en.wikipedia.org.
22. Xcode Life. “2020 Update: You Need To Know This Before You Buy Family Tree DNA!” Accessed August 2026. xcode.life.
23. Anglo-Celtic Connections. “MyHeritage Does Y-DNA” (ownership timing). August 20, 2026. anglocelticconnections.ca.
24. Inc.com / Reuters. “Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale.” May 19, 2025. inc.com.
25. ElevenFlo. “23andMe: From $6B Unicorn to $305M Nonprofit Sale in Chapter 11.” Accessed August 2026. elevenflo.com.

Note: This post was researched and written with the assistance of artificial intelligence (AI). All content has been reviewed for accuracy as of August 2026. All errors are the responsibility of the author.